JPS56500254A - - Google Patents

Info

Publication number
JPS56500254A
JPS56500254A JP50062580A JP50062580A JPS56500254A JP S56500254 A JPS56500254 A JP S56500254A JP 50062580 A JP50062580 A JP 50062580A JP 50062580 A JP50062580 A JP 50062580A JP S56500254 A JPS56500254 A JP S56500254A
Authority
JP
Japan
Prior art keywords
prostaglandin
residues
linked
molecular weight
average molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP50062580A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0323530B2 (enExample
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS56500254A publication Critical patent/JPS56500254A/ja
Publication of JPH0323530B2 publication Critical patent/JPH0323530B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/48—Polyethers
    • C08G18/4833—Polyethers containing oxyethylene units
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/65—Low-molecular-weight compounds having active hydrogen with high-molecular-weight compounds having active hydrogen
    • C08G18/66—Compounds of groups C08G18/42, C08G18/48, or C08G18/52
    • C08G18/6666—Compounds of group C08G18/48 or C08G18/52
    • C08G18/667—Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38
    • C08G18/6674—Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/3203
    • C08G18/6677—Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/3203 having at least three hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2210/00—Compositions for preparing hydrogels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2250/00—Compositions for preparing crystalline polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Lubricants (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fluid-Damping Devices (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP55500625A 1979-03-21 1980-03-21 Expired - Lifetime JPH0323530B2 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7909853 1979-03-21

Publications (2)

Publication Number Publication Date
JPS56500254A true JPS56500254A (enExample) 1981-03-05
JPH0323530B2 JPH0323530B2 (enExample) 1991-03-29

Family

ID=10504015

Family Applications (2)

Application Number Title Priority Date Filing Date
JP55500624A Expired - Lifetime JPH0323529B2 (enExample) 1979-03-21 1980-03-21
JP55500625A Expired - Lifetime JPH0323530B2 (enExample) 1979-03-21 1980-03-21

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP55500624A Expired - Lifetime JPH0323529B2 (enExample) 1979-03-21 1980-03-21

Country Status (11)

Country Link
US (2) US4931288A (enExample)
EP (2) EP0016652B1 (enExample)
JP (2) JPH0323529B2 (enExample)
AT (2) ATE15444T1 (enExample)
AU (2) AU537740B2 (enExample)
DE (2) DE3071070D1 (enExample)
GB (2) GB2047094B (enExample)
HK (2) HK79885A (enExample)
NZ (2) NZ193222A (enExample)
WO (2) WO1980001985A1 (enExample)
ZA (2) ZA801654B (enExample)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079009A (en) * 1979-03-21 1992-01-07 National Research Development Corporation Controlled release compositions including polyethylene oxide with urethane cross-linking
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
US4466936A (en) * 1981-02-03 1984-08-21 Bayer Aktiengesellschaft Production of molds using gel compositions with depot action based on a polyurethane matrix and relatively high molecular weight polyols
AU558611B2 (en) * 1981-02-03 1987-02-05 Bayer Aktiengesellschaft Polyurethane gel
DE3272562D1 (en) * 1981-06-12 1986-09-18 Nat Res Dev Preparation of particulate gels
DE3280021D1 (en) * 1981-06-12 1989-12-21 Nat Res Dev Hydrogels
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
FR2539135B1 (fr) * 1983-01-11 1986-02-28 Essilor Int Hydrogels de polyurethane et procede de fabrication
GB2135881B (en) * 1983-03-02 1986-09-17 Erba Farmitalia Pharmaceutical compositions for inhibiting or reducing gastrointestinal side effects of non-steroidal anti-inflammatory drugs
EP0132690B1 (de) * 1983-07-21 1989-02-01 Troponwerke GmbH & Co. KG Antiphlogistika enthaltende thermoplastische Kunststoffe
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
IL72041A (en) * 1984-06-05 1990-01-18 Elka Touitou Preparation for controlled release of iodine
US5439966A (en) * 1984-07-12 1995-08-08 National Research Development Corporation Polyethylene oxide temperature - or fluid-sensitive shape memory device
FR2582944B1 (fr) * 1985-06-11 1990-10-26 Commissariat Energie Atomique Piece en polymere, notamment en polyurethane de polyoxyethylene a gonflement anisotrope, son procede de fabrication et son utilisation comme dilatateur du col uterin
EP0347145A3 (en) * 1988-06-14 1990-10-24 University Of Utah Research Foundation Heterogeneous interpenetrating polymer networks for the controlled release of drugs
US5342624A (en) * 1989-02-16 1994-08-30 British Technology Group Ltd. Dispensing device
ES2072976T3 (es) * 1989-03-17 1995-08-01 Ono Pharmaceutical Co Poliuretanos biodegradables.
US5225514A (en) * 1989-03-17 1993-07-06 Ono Pharmaceutical Co., Ltd. Azo containing polyurethanes for drug delivery to the large intestines
GB8918589D0 (en) * 1989-08-15 1989-09-27 Graham Neil B Polymeric compositions
US5833665A (en) * 1990-06-14 1998-11-10 Integra Lifesciences I, Ltd. Polyurethane-biopolymer composite
US5827925A (en) * 1990-07-26 1998-10-27 Monsanto Company Polymeric drug delivery system
AU653771B2 (en) * 1991-01-03 1994-10-13 Alkermes Controlled Therapeutics, Inc. Stabilization of proteins by cationic biopolymers
GB2254002B (en) * 1991-01-16 1995-03-22 Controlled Therapeutics Retrievable pessary
GB9101502D0 (en) * 1991-01-23 1991-03-06 Controlled Therapeutics Sct Controlled release compositions
US5273742A (en) * 1991-12-30 1993-12-28 Tyndale Plains-Hunter Ltd. Biomedical water soluble hydrophilic polyurethane polymers and method of use thereof
GB9313017D0 (en) * 1993-06-24 1993-08-11 Univ Strathclyde Measurement of water content
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
US6322815B1 (en) 1994-07-22 2001-11-27 W. Mark Saltzman Multipart drug delivery system
GB9418483D0 (en) * 1994-09-14 1994-11-02 British Tech Group Compound for use in pre-term labour
GB2295316B (en) * 1994-11-25 1997-09-10 William Leslie Porter Bolus for supplying biologically beneficial substances to ruminant animals
GB9506946D0 (en) * 1995-04-04 1995-05-24 Univ Strathclyde Microgels
US20020064546A1 (en) 1996-09-13 2002-05-30 J. Milton Harris Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
US6258351B1 (en) 1996-11-06 2001-07-10 Shearwater Corporation Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
DE19734538C1 (de) * 1997-07-30 1998-12-24 Jenapharm Gmbh Bioadhäsive Tablette
US6362276B1 (en) * 1998-01-07 2002-03-26 Debio Recherche Pharmaceutique S.A. Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom
US6514534B1 (en) 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
GB9826192D0 (en) * 1998-12-01 1999-01-20 Controlled Theraputics Scotlan Oral transmucosal delivery
US7265186B2 (en) * 2001-01-19 2007-09-04 Nektar Therapeutics Al, Corporation Multi-arm block copolymers as drug delivery vehicles
TWI246524B (en) * 2001-01-19 2006-01-01 Shearwater Corp Multi-arm block copolymers as drug delivery vehicles
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
AU2003300140A1 (en) 2002-12-31 2004-07-29 Nektar Therapeutics Al, Corporation Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof
US7794657B2 (en) 2003-06-03 2010-09-14 Cantimer, Inc. Phase change sensor
US20040259744A1 (en) * 2003-12-19 2004-12-23 Meidong Yang Skin and hair cleansers containing sulfur
US7282584B2 (en) * 2004-06-16 2007-10-16 Straumann Holding Ag Methylene blue
DE602004011660T2 (de) * 2004-06-16 2009-01-29 Straumann Holding Ag Abdeckmembran
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
WO2006133048A2 (en) * 2005-06-03 2006-12-14 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same
US8568705B2 (en) * 2005-07-18 2013-10-29 Nektar Therapeutics Method for preparing branched functionalized polymers using branched polyol cores
DE102005053066A1 (de) * 2005-11-04 2007-05-10 Basf Ag Verwendung von Copolymeren als Solubilisatoren für in Wasser schwerlöslichen Verbindungen
WO2007065846A2 (de) * 2005-12-09 2007-06-14 Basf Se Verwendung von polyvinyllactam-polyoxyalkylen-blockcopolymeren als solubilisatoren für in wasser schwerlösliche verbindungen
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
RU2444364C2 (ru) * 2006-07-12 2012-03-10 Контроллд Терапьютикс (Скотлэнд) Лтд. Полимер для доставки лекарств с гидрохлоридной солью клиндамицина
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
JP2010534730A (ja) * 2007-07-26 2010-11-11 ビーエーエスエフ ソシエタス・ヨーロピア 溶液中でのグラフト重合により得られる、ポリエーテルに基づく固体形態のコポリマーの調製方法
KR20100120665A (ko) 2008-01-25 2010-11-16 더 유니버시티 오브 유타 리서치 파운데이션 일차 방출 중합체
DE102009052948B4 (de) * 2009-11-12 2013-05-29 Rkw Se Silageabdeckung
US9205089B2 (en) 2011-04-29 2015-12-08 Massachusetts Institute Of Technology Layer processing for pharmaceuticals
GB201110601D0 (en) 2011-06-23 2011-08-03 Controlled Therapeutics Scotland Ltd Improved bioresorbable
EP2689781A1 (en) 2012-07-26 2014-01-29 Ferring B.V. Misoprostol composition
EP2689802A1 (en) 2012-07-26 2014-01-29 Ferring B.V. Misoprostol formulation
AU2013294960B2 (en) 2012-07-26 2018-04-19 Ferring B.V. Misoprostol Composition
EP2754443A1 (en) 2013-01-09 2014-07-16 Ferring B.V. Misoprostol for the induction of labour
JP2015522645A (ja) 2012-07-26 2015-08-06 フェリング ベスローテン フェンノートシャップ ミソプロストール処方物
EP2754442A1 (en) 2013-01-09 2014-07-16 Ferring B.V. Misoprostol for the induction of labour
WO2015179461A1 (en) 2014-05-20 2015-11-26 Massachusetts Institute Of Technology Plasticity induced bonding
GB201916808D0 (en) 2019-11-19 2020-01-01 Ferring Bv Pharmaceutical delivery device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975350A (en) * 1972-08-02 1976-08-17 Princeton Polymer Laboratories, Incorporated Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles
FR2373279A1 (fr) * 1976-12-13 1978-07-07 Ici Ltd Composition a base d'un copolymere sequence pour la liberation prolongee d'un agent doue d'activite biologique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1050353B (it) * 1966-01-06 1981-03-10 Ceskoslovenska Akademie Ved Supporti per sostanze biologigamente attive
US3822238A (en) * 1972-08-02 1974-07-02 Princeton Polymer Lab Hydrophilic polyurethane polymers
US3953406A (en) * 1973-01-26 1976-04-27 California Institute Of Technology Water-insoluble, swellable polyurethanes
US3993551A (en) * 1973-09-10 1976-11-23 Union Carbide Corporation Process for cocrosslinking water soluble polymers and products thereof
FR2250793B1 (enExample) * 1973-11-09 1978-12-29 Commissariat Energie Atomique
GB1494814A (en) * 1976-07-14 1977-12-14 Sanyo Chemical Ind Ltd Agrochemical compositions
SE431821B (sv) * 1979-01-29 1984-03-05 Perstorp Ab Lagringsstabilt, prostaglandininnehallande medicinskt preparat

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975350A (en) * 1972-08-02 1976-08-17 Princeton Polymer Laboratories, Incorporated Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles
FR2373279A1 (fr) * 1976-12-13 1978-07-07 Ici Ltd Composition a base d'un copolymere sequence pour la liberation prolongee d'un agent doue d'activite biologique

Also Published As

Publication number Publication date
WO1980001984A1 (en) 1980-10-02
AU5669080A (en) 1980-09-25
ZA801654B (en) 1981-10-28
EP0016652A1 (en) 1980-10-01
ZA801659B (en) 1981-10-28
EP0016652B1 (en) 1985-08-21
AU537741B2 (en) 1984-07-12
EP0016654A1 (en) 1980-10-01
EP0016654B1 (en) 1985-09-11
JPS56500253A (enExample) 1981-03-05
GB2047093B (en) 1983-12-07
US4931288A (en) 1990-06-05
HK79785A (en) 1985-10-25
NZ193221A (en) 1984-08-24
ATE15444T1 (de) 1985-09-15
GB2047094B (en) 1983-12-07
DE3071070D1 (en) 1985-10-17
JPH0323529B2 (enExample) 1991-03-29
HK79885A (en) 1985-10-25
GB2047094A (en) 1980-11-26
NZ193222A (en) 1984-08-24
WO1980001985A1 (en) 1980-10-02
ATE14979T1 (de) 1985-09-15
AU5669180A (en) 1980-09-25
DE3071006D1 (en) 1985-09-26
GB2047093A (en) 1980-11-26
AU537740B2 (en) 1984-07-12
JPH0323530B2 (enExample) 1991-03-29
US4894238A (en) 1990-01-16

Similar Documents

Publication Publication Date Title
JPS56500253A (enExample)
GB2066268B (en) Ethylene polymer composition
AU3618484A (en) Bioadhesive compositions and methods of treatment therewith
AU529762B2 (en) Olefin polymerization catalyst compositions
AU552101B2 (en) Ethylene copolymer composition
AU5830780A (en) Olefin polymerization catalyst composition
EP0300689A3 (en) High flow drapable polymer compositions
ZA776986B (en) Highly absorbent polymeric compositions from polyhydroxy polymer graft copolymers
JPS55108446A (en) Airtight polymer composition
AU509255B2 (en) Self-extinguishing polymeric composition
EP0281336A3 (en) Composition for non-crosslinked foam
GB2021125B (en) Biosynthetic polymeric compositions
AU551060B2 (en) Polyurethane-forming composition comprising addition polymer
EP0264193A3 (en) Non-crosslinked foam
JPS57155251A (en) Polyurethane matrix and gel composition based on considerably high molecular polyol and containing active component spontaneously, their manufacture and use
NZ231990A (en) Catalyst composition for regulating the molecular weight distribution of ethylene polymers
AU7873781A (en) Oxazolines, hydro-1,3-oxazines, hydro-1,3-oxazepines and their, sulphur and nitrogen analogues
AU6956881A (en) Peroxide polymerisation catalyst composition
AU555710B2 (en) Cross-linked urea-formaldehyde polymer matrix compositions containing cyclic intermediate structures
DE3361052D1 (en) Process for preparing block copolymers based on ethylene polymers and other polymers
AU5310879A (en) Ethylene copolymer composition
JPS5676454A (en) High molecular composition
DE3376005D1 (en) Process for the manufacture of block copolymers on the basis of polymerisates of ethylene and other polymers
JPS5598406A (en) Semiconductive high molecular composition
AU533596B2 (en) Biosynthetic polymeric composition